🔎 Trials Near Me

Home › Non-Muscle Invasive Bladder Cancer › Pennsylvania › Philadelphia

Non-Muscle Invasive Bladder Cancer clinical trials in Philadelphia, PA

7 studies for Non-Muscle Invasive Bladder Cancer are looking for participants at sites in and around Philadelphia (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy

RecruitingPhase 3
  • Fox Chase Cancer Center, Philadelphia
  • Fox Chase Cancer Center-Rockledge, Rockledge · 10 mi away
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT07000084

A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)

RecruitingPhase 2
  • MidLantic Urology ( Site 0102), Bala-Cynwyd · 5 mi away
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT06833073

Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer

RecruitingPhase 2
  • MidLantic Urology, Bala-Cynwyd · 5 mi away
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT06995677

A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer

RecruitingPhase 3
  • MidLantic Urology, Bala-Cynwyd · 5 mi away
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06919965

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

RecruitingPhase 1
  • University of Pennsylvania, Philadelphia
  • Thomas Jefferson University, Philadelphia
Ages 18 and older · All sexes · Updated Aug 20, 2026 · NCT05614739

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

RecruitingPhase 1/2
  • Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
Ages 18 and older · All sexes · Updated Aug 7, 2026 · NCT04752722

ResQ133A-NMIBC: Intravesical Recombinant Mycobacterium (rMBCG) in Participants With NMIBC Eligible to Receive Intravesical Tice BCG

RecruitingPhase 1/2
  • MidLantic Urology, Cynwyd · 5 mi away
Ages 18 to 85 · All sexes · Updated Mar 27, 2026 · NCT06800963

Non-Muscle Invasive Bladder Cancer trials in other cities

Other studies in Philadelphia

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.